**Core Concept**
Autoimmune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by isolated thrombocytopenia, resulting from the immune system's destruction of platelets. This process is mediated by autoantibodies against platelet antigens.

**Why the Correct Answer is Right**
The correct answer involves the production of autoantibodies against platelet antigens, specifically against the glycoproteins IIb/IIIa (GPIIb/IIIa) on the platelet surface. These autoantibodies are primarily IgG antibodies, which activate the complement system and the platelet destruction process. This results in the removal of platelets from the circulation, leading to a decrease in platelet count.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as it does not specify the involvement of autoantibodies or the immune system in ITP. ITP is not caused by a deficiency in platelet production or a problem with platelet function.
* **Option B:** This option is incorrect as it does not accurately describe the pathophysiology of ITP. Platelet activation does not lead to the production of autoantibodies or the activation of the complement system.
* **Option C:** This option is incorrect as it does not specify the role of the immune system in ITP. While infections can trigger ITP, they do not cause the disease.

**Clinical Pearl / High-Yield Fact**
One important aspect of ITP is that the platelet count can fluctuate over time, and some patients may experience spontaneous remission. However, in many cases, ITP can be treated with corticosteroids, immunoglobulins, or splenectomy to reduce platelet destruction.

**Correct Answer: C. Infection.**